Verastem Inc

Financials

Total assets 154.35 M108.66 M95.05 M149.72 M101.54 M246.44 M Total liabilities 39.08 M21.1 M47.66 M71.19 M130.43 M189.25 M Total equity 115.27 M87.56 M47.39 M57.37 M-28.89 M57.2 M Total liabilities & shareholders' equities 154.35 M108.66 M95.05 M149.72 M101.54 M246.44 M Total debt 19.05 M249 K24.8 M40.09 M40.72 M76.33 M Net debt -144.01 M-97.12 M-61.11 M-95.57 M-46.55 M-128.13 M

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

VSTM

Financials

Verastem Inc

뉴스

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com

Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market

Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play (NASDAQ:VSTM)

Verastem, BTIG ’매수’ 등급 시작, 목표 주가 19달러 제시

Verastem stock initiated at Buy by BTIG with $19 price target

Wall Street Analysts See a 159.31% Upside in Verastem (VSTM): Can the Stock Really Move This High?

제퍼리스, Verastem 목표 주가 유지…출시 순항 평가

Jefferies reiterates Verastem stock rating on launch progress

Verastem, Inc. (VSTM) Q4 2025 Earnings Call Transcript

Verastem (VSTM) Reports Q4 Loss, Beats Revenue Estimates

3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com